Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. Most relevant
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
2017LTL Pharma Co., Ltd completed the acquisition of 16 long-listed products in J..
CI
2017Astellas Pharma Inc. Reports Consolidated Earnings Results for the Fourth Qua..
CI
2017Astellas Pharma Mulls Acquisitions
CI
2017ASTELLAS PHARMA : Announces Cancellation of Treasury Shares (pdf 266KB)
PU
2017ASTELLAS PHARMA : Reports Full Year FY2016 Financial Results (462 KB)
PU
2017ASTELLAS PHARMA : Announces Cancellation of Treasury Shares
PU
2017ASTELLAS PHARMA : Changes of Representative Directors and Directors (pdf 294KB)
PU
2017ASTELLAS PHARMA : Reports Full Year FY2016 Financial Results
BU
2017Astellas Pharma, Inc. Reports Consolidated Earnings Results for the Fiscal Ye..
CI
2017ASTELLAS PHARMA : to Acquire Ogeda SA (pdf 306KB)
PU
2017Astellas Pharma Inc. entered into a definitive agreement to acquire Ogeda SA ..
CI
2017ASTELLAS PHARMA INC : Ex-dividend day for final dividend
FA
2017LTL Pharma Co., Ltd have entered into an asset purchase agreement to acquire ..
CI
2017ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 189KB)
PU
2017Tranche Update on Astellas Pharma Inc.'s Equity Buyback Plan announced on Jan..
CI
2017Ribomic Enters into Research Agreement with Astellas Pharma
CI
2017Astellas Pharma Inc. Launches a Guanylate Cyclase-C (GC-C) Receptor Agonist, ..
CI
2017Astellas Pharma Inc.'s Equity Buyback announced January 31, 2017 has closed w..
CI
2017ASTELLAS PHARMA : Launch of LINZESS« Tablets 0.25mg in Japan
PU
2017ASTELLAS PHARMA : and Affinivax Announce Worldwide Partnership for MAPS Vaccine ..
PU
2017Kyowa Pharmaceutical Industry Co., Enters into Agreement with Astellas Pharma..
CI
2017ASTELLAS PHARMA : Kyowa and Astellas enter into an Agreement for Exclusive Distr..
PU
2017ASTELLAS PHARMA : Joint Storage and Transportation of Pharmaceuticals in Hokkaid..
PU
2017ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes (pdf 39..
PU
2017ASTELLAS PHARMA : Announces Changes in Management Structure and Global Function ..
PU
2017GenomeDx Biosciences Announces Research Collaboration with Astellas to Identi..
CI
2017Astellas Executes License Agreement with Auration Biotech for Development, Co..
CI
2017Astellas Pharma, Inc. authorizes a Buyback Plan.
CI
2017Astellas Pharma Inc. announces an Equity Buyback for 30,000,000 shares, repre..
CI
2017ASTELLAS PHARMA : Reports the First Nine Months Financial Results of FY2016
BU
2017Astellas Pharma Inc. Announces Consolidated Earnings Results for Three Quarte..
CI
2017ASTELLAS PHARMA : Reports the First Nine Months Financial Results of FY2016 (pdf..
PU
2017ASTELLAS PHARMA : Executes License Agreement with Auration Biotech for the Devel..
PU
2017ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 190KB)
PU
2017ASTELLAS PHARMA : Announces Participation in Access Accelerated - Builds on Comp..
PU
2017ASTELLAS PHARMA : Launches Second Phase of Global Campaign on CNN
PU
2017Astellas Pharma Inc. Terminates Agreement with UMN Pharma for Cell Culture Ba..
CI
2017ASTELLAS PHARMA : Terminates Agreement with UMN Pharma for Cell Culture Based In..
PU
2016Tranche Update on Astellas Pharma Inc.'s Equity Buyback Plan announced on Oct..
CI
2016ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares
PU
2016Astellas Pharma Inc.'s Equity Buyback announced on October 28, 2016 has close..
CI
2016ASTELLAS PHARMA : Completes Acquisition of Ganymed Pharmaceuticals
PU
2016Sysmex, Astellas, and Daiichi Sankyo Sign Memorandum of Understanding to Crea..
CI
2016Amgen Astellas Biopharma K.K. and Astellas Pharma Inc Announces Submission of..
CI
2016Astellas Pharma Inc. Announces FDA Fast Track Designation for ASP0892
CI
2016Astellas Pharma, Inc. completed the acquisition of Ganymed Pharmaceuticals AG..
CI
2016ASTELLAS PHARMA : Amgen astellas and astellas announce submission of application..
PU
2016ASTELLAS PHARMA : Announces FDA Fast Track Designation for ASP0892, DNA Vaccine ..
PU
2016Astellas Pharma Inc. Receives Marketing Approval of Guanylate Cyclase-C (GC-C..
CI
2016ASTELLAS PHARMA : Marketing Approval of LINZESS«, Treatment for Irritable Bowel ..
PU
2016ASTELLAS PHARMA : Sysmex, Astellas and Daiichi Sankyo Sign Memorandum of Underst..
PU
2016ASTELLAS PHARMA : Pfizer and Astellas Announce Top-Line Results from Phase 4 PLA..
PU
2016Pfizer Inc. and Astellas Pharma Inc. Announce Top-Line Results from Phase 4 P..
CI
2016ASTELLAS PHARMA : Research & Development Meeting Highlights
BU
2016Astellas Launches Kiklin Granules, Treatment for Hyperphosphatemia in Japan
CI
2016ASTELLAS PHARMA : Initiatives to Pursue Operational Excellence
PU
2016ASTELLAS PHARMA : Antihypertensive Drug "Micatrio« Combination Tablets"
PU
2016ASTELLAS PHARMA : GUINNESS WORLD RECORDSTM Title Achieved for Organ Donor Regist..
PU
2016ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 187KB)
PU
2016Astellas Pharma, Inc. announces an Equity Buyback for 30,000,000 shares, repr..
CI
2016Astellas Pharma, Inc. entered into an agreement to acquire Ganymed Pharmaceut..
CI
2016Astellas Pharma, Inc. authorizes a Buyback Plan.
CI
2016Astellas Pharma Seeks Acquisitions
CI
2016ASTELLAS PHARMA : Reports First Half FY2016 Financial Results, Revises Fiscal Ye..
BU
2016Astellas Pharma Inc. Announces Consolidated Earnings Results for the Six Mont..
CI
2016ASTELLAS PHARMA : to Acquire Ganymed Pharmaceuticals -Acquisition Would Expand '..
PU
2016ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 175KB)
PU
2016ASTELLAS PHARMA : Reports First Half FY2016 Financial Results, Revises Fiscal Ye..
PU
2016ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI in A..
PU
2016Astellas Pharma Inc. and Pfizer Inc. Announces FDA Approval for Supplemental..
CI
2016ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
PU
2016ASTELLAS PHARMA : Chromocell and Astellas Announce FDA Fast Track Designation an..
PU
2016Chromocell and Astellas Announce FDA Fast Track Designation and First Subject..
CI
2016ASTELLAS PHARMA : Filed Lawsuit against Patent Infringement of Myrbetriq« in the..
PU
2016Astellas Pharma Inc. Announces Executive Appointments
CI
Prev.3  4  5  6  7   8  9  10  11  12Next
Upcoming event on ASTELLAS PHARMA INC.
07/30/21